Atossa Therapeutics
ATOS
#10505
Rank
C$33.84 M
Marketcap
C$3.39
Share price
-0.82%
Change (1 day)
179.50%
Change (1 year)

Atossa Therapeutics (ATOS) - Net assets

Net assets on the balance sheet as of March 2026 : C$42.92 Million

According to Atossa Therapeutics's latest financial reports the company has C$42.92 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Atossa Therapeutics - Net assets on balance sheet (from 2010 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$C$53.89 M-47.46%
2024-12-31$C$0.10 B-15.04%
2023-12-31$C$0.12 B-24.58%
2022-12-31$C$0.16 B-9.07%
2021-12-31$C$0.17 B408.2%
2020-12-31$C$34.64 M101.61%
2019-12-31$C$17.18 M43.26%
2018-12-31$C$11.99 M37.49%
2017-12-31$C$8.72 M109.6%
2016-12-31$C$4.16 M-19.81%
2015-12-31$C$5.19 M-52.91%
2014-12-31$C$11.02 M-2.33%
2013-12-31$C$11.28 M119.28%
2012-12-31$C$5.14 M224.39%
2011-12-31$C$1.58 M-286.32%
2010-12-31$-C$0.86 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
C$114.30 B 266,205.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
C$10.90 B 25,305.10%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$12.31 B 28,586.94%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
C$1.16 B 2,618.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
C$61.1 M 42.35%๐Ÿ‡บ๐Ÿ‡ธ USA